Biohaven Ltd. (BHVN) Q4 2020 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biohaven Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:03.852 Good morning. Welcome to BioHaven Pharmaceuticals' fourth quarter 2020 and full year 00:00:03.852 -- 00:00:08.395 results call. At this time, all participants' lines are in listen-only mode. 00:00:08.395 -- 00:00:11.678 After the speaker's presentation, there will be a question and answer session. 00:00:11.678 -- 00:00:14.880 If anyone should require operator assistance during the conference, please press star 00:00:14.880 -- 00:00:17.162 zero on your telephone keypad. 00:00:17.162 -- 00:00:20.805 Please be advised that today's conference call may be recorded. 00:00:20.805 -- 00:00:25.308 I would now like to hand the conference over to BioHaven's Chief Operating Officer, Clifford 00:00:25.308 -- 00:00:26.710 Bechtold. 00:00:26.710 -- 00:00:28.911 Thank you, and you may now begin. 00:00:28.911 -- 00:00:32.717 Good morning, and thank you. And welcome to the Biohaven's fourth quarter 2020 earnings 00:00:32.717 -- 00:00:34.717 call. 00:00:34.878 -- 00:00:40.280 Speaking on today's call are Dr. Vlad Torch, our Chief Executive Officer, Jim Englehart, 00:00:40.280 -- 00:00:45.062 Chief Financial Officer, Vijay Jones, Chief Commercial Officer, and Dr. 00:00:45.062 -- 00:00:48.224 Elise Stock, our Chief Medical Officer. 00:00:48.224 -- 00:00:52.025 Earlier this morning, we issued a press release announcing the fourth quarter 2020 highlights 00:00:52.025 -- 00:00:54.826 and a summary of our year-end results. 00:00:54.826 -- 00:00:59.602 A copy of this press release can be found on our website at biohavenfarmer.com 00:00:59.602 -- 00:01:05.665 and will be on file with the 10Q later filed today. 00:01:06.348 -- 00:01:10.051 Before we begin, let me remind everybody that today's discussion contains forward-looking 00:01:10.051 -- 00:01:12.953 st...